Score Overview
Co-Diagnostics, Inc. Common Stock fundamental performance
Between 2020 and 2025, revenue declined from $ 74M to $ 622.49K and net income went from $ 42M to -$ 46M. Revenue increased in 1 of those 5 years; net income in 0.
Across Co-Diagnostics, Inc. Common Stock's full reported history, from 2017 to 2025, revenue grew from $ 7.66K to $ 622.49K and net income went from -$ 6M to -$ 46M. Revenue increased in 50% of the years measured; net income in 38%.
Co-Diagnostics, Inc. Common Stock currently holds a 5-year HDB Score of 0.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.48 | — |
1 Year2025-08-12 | $ 7.61 | -80.55% |
5 Years2021-08-12 | $ 290.10 | -99.49% |
All Time2017-07-12 | $ 174.30 | -99.15% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-07-12 |
|---|---|---|---|---|
| Price | $ 1.48 | $ 7.61 | $ 290.10 | $ 174.30 |
| Return | — | -80.55% | -99.49% | -99.15% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 622.49K | -$ 46M | $ 11M |
| 2024 | $ 3M | -$ 37M | $ 29M |
| 2023 | $ 6M | -$ 35M | $ 58M |
| 2022 | $ 34M | -$ 14M | $ 81M |
| 2021 | $ 97M | $ 36M | $ 89M |
| 2020 | $ 74M | $ 42M | $ 47M |
| 2019 | $ 214.97K | -$ 6M | $ 893.14K |
| 2018 | $ 39.91K | -$ 6M | $ 950.24K |
| IPO2017 | $ 7.66K | -$ 6M | $ 3M |
Explore beyond CODX
You're looking at Co-Diagnostics, Inc. Common Stock. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
